Home/Filings/4/0001209191-21-056096
4//SEC Filing

Lenk Robert P 4

Accession 0001209191-21-056096

CIK 0001095981other

Filed

Sep 14, 8:00 PM ET

Accepted

Sep 15, 7:30 AM ET

Size

5.2 KB

Accession

0001209191-21-056096

Insider Transaction Report

Form 4
Period: 2021-09-13
Transactions
  • Purchase

    Common Stock

    2021-09-13$1.86/sh+7,000$13,01110,000 total
Footnotes (1)
  • [F1]The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.8499 to $1.859 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Issuer

PLUS THERAPEUTICS, INC.

CIK 0001095981

Entity typeother

Related Parties

1
  • filerCIK 0001362635

Filing Metadata

Form type
4
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 7:30 AM ET
Size
5.2 KB